V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER ISSN 1068-1760
Vol. 35 No.5 • 8-9/2018
DAILY CLINICAL LAB NEWS
®
I
N
T
E
R
Early Sepsis Indicator Alerts Emergency Clinicians epsis is an often-deadly condition that affects 26 million people worldwide every year and is increasing at a rate of 1.5% annually. Timely and accurate detection solutions in the acute-care setting are key components to stopping the progression of sepsis,
S
N
A
T
I
O
Cutting-Edge Technology Applied to Grading Cancer Tumors iopsy specimens are processed into formalin-fixedparaffin-embedded (FFPE) blocks and currently, hematoxylin and eosin (H + E) stained sections are widely used for the histopathological diagnosis of cancer and other pathologies.
B
Typically the sections are graded subjectively by eye, using disease-specific grading protocols. Histological grading of breast cancer currently varies widely across multiple institutions and practitioners, because it relies on subjective criteria. However an analysis
Cont’d on page 5
Cont’d on page 8
Image: Courtesy of The Children’s Lyme Disease Network
Antigen Matching Advance Could Transform Transfusion Medicine
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
Access Interactive Digital Magazine Instant Online Product Information: Identify LinkXpress codes of 1 interest as you read magazine ®
on LinkXpress.com 2 Click to reach reader service portal
3
Mark code(s) of interest on LinkXpress ® inquiry matrix
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
new blood test for determination of prostate cancer risk was found to be more accurate than the current gold standard PSA (prostate specific antigen) test. Prostate-specific antigen, the current gold standard in prostate cancer detection, is distinct from virtually all other cancer biomarkers because of its almost exclusive specificity to the prostate, allowing
A
hronic infection with hepatitis C virus (HCV) is a major public health problem, estimated to infect 1.0% of the world’s population (71 million people) and to be responsible for 400, 000 annual deaths as a result of cirrhosis and liver cancer. A hand-held, portable device that weighs approximately 600 grams or a little more than 21 ounces has been validated as a Cont’d on page 6
Fully Automated System Simplifies Sample Prep and Analysis
P O R T A L
Renew /Start your Free Subscription
More Accurate Test for Prostate Cancer Risk
C
See article on page 4
S
L
Near-Patient Hepatitis C Assay Validated
ased on the application of advanced whole-genome sequencing techniques, antigen typing can enable more precise antigen matching of patients with blood donors, thus preventing complications of sensitization to antigens and materially improving transfusion outcomes.
I
A
Cont’d on page 4
B
V
N
fully automated LC-MS/ MS system simplifies and accelerates the collection of high quality, reliable data by reducing the need to perform repeated runs, which gives clinical scientists increased confidence in the validity of results.
A
Cont’d on page 5
SHERLOCK Diagnostic Platform Optimized for Rapid Viral Detection new technique enables the SHERLOCK diagnostic platform to detect a virus directly in bodily fluids, eliminating a step that required laboratory equipment and expanding the platform’s potential to quickly and cheaply track pathogens such as Zika
A
during an outbreak. The platform can now be used to detect viruses directly in clinical samples such as blood or saliva, eliminating a processing step that previously required a laboratory environment and professionally trained personnel. Cont’d on page 7
INSIDE Clinical News . . . . 2-26 IFCC News . . . . . . . . 27 Product News . . . 8-26 Industry News . . . . .33 Events Calendar . . . 34 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<